Clinical trial
The INFLUENCE of Cytoreduction on Patient Reported Outcomes in Patients With Epithelial Ovarian Cancer
NCT03268876 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The INFLUENCE of Cytoreduction on Patient Reported Outcomes in Patients With Epithelial Ovarian Cancer
- Lead sponsor
- Haukeland University Hospital
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- March 3, 2021
- Completion date
- December 31, 2030
- Enrollment
- 70 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
epithelial ovarian cancer